🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Feasibility and Acceptability of Group Medical Visits for Anxiety and Depression

RecruitingNAAges 18 Years - anyAllUniversity of Manitoba
NCT06651801 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The goal of this clinical trial is to evaluate the feasibility and acceptability of the intervention, Group Medical Visits (GMVs), for patients with depression and anxiety. It also aims to get some initial information on the effectiveness of GMVs on reducing depression and anxiety scores, which will help inform power calculations for a future larger randomized controlled trial (RCT). The main question it aims to answer is: * Are GMVs feasible and acceptable to patients with depression and anxiety? This study consists of a pilot RCT with an intervention and control arm. At enrollment, participants will be randomized to the intervention group, 6 months of GMVs, or to the control group, which consists of "standard client services". For the GMV group, participants will engage in a biweekly virtual group that is similar to a standard psychiatric follow-up. Participants in the control group

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Adult patients who are looking for longitudinal psychiatric follow-up after a one-time consult or discharge from a mental health program. * Primary mental health issue is an anxiety or depressive disorder. * Able to commit to a virtual biweekly group on Tuesdays from 2:30-4PM. * Able to do virtual group from a private location with camera access. * Live in community in Manitoba and plan to stay for a 6-month period. Exclusion Criteria: * Patients with confirmed Bipolar 1 or 2 Disorder. * Patients who already have longitudinal care with a psychiatrist. * Received ECT treatment within past 6 months. * Concern about safety of other group members/facilitators if this patient were to join. * Any co-morbidity/behaviour that would significantly impact ability to participate in the group. For example: * Severe substance use disorder. * Significant PTSD or OCD symptoms that would impact group participation. * Severe personality disorder. * Current psychotic symptoms. * Moderate to severe intellectual disability or neurocognitive disorder. * Current significant eating disorder symptoms. * Self-harm behaviour requiring medical/psychiatric attention or suicide attempt within the past 6 months.
💊

What it tests

  • Group Medical Visits
📍

Where

1 site
PsycHealth Centre
Winnipeg, Canada
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy